BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 24256636)

  • 1. Heat shock factor 1 over-expression protects against exposure of hydrophobic residues on mutant SOD1 and early mortality in a mouse model of amyotrophic lateral sclerosis.
    Lin PY; Simon SM; Koh WK; Folorunso O; Umbaugh CS; Pierce A
    Mol Neurodegener; 2013 Nov; 8():43. PubMed ID: 24256636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice.
    Lelie HL; Liba A; Bourassa MW; Chattopadhyay M; Chan PK; Gralla EB; Miller LM; Borchelt DR; Valentine JS; Whitelegge JP
    J Biol Chem; 2011 Jan; 286(4):2795-806. PubMed ID: 21068388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system.
    Watanabe S; Ageta-Ishihara N; Nagatsu S; Takao K; Komine O; Endo F; Miyakawa T; Misawa H; Takahashi R; Kinoshita M; Yamanaka K
    Mol Brain; 2014 Aug; 7():62. PubMed ID: 25167838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS.
    Nagano S; Takahashi Y; Yamamoto K; Masutani H; Fujiwara N; Urushitani M; Araki T
    Hum Mol Genet; 2015 Jun; 24(12):3427-39. PubMed ID: 25762155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
    Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
    Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS).
    Crippa V; Sau D; Rusmini P; Boncoraglio A; Onesto E; Bolzoni E; Galbiati M; Fontana E; Marino M; Carra S; Bendotti C; De Biasi S; Poletti A
    Hum Mol Genet; 2010 Sep; 19(17):3440-56. PubMed ID: 20570967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network.
    Wei R; Bhattacharya A; Hamilton RT; Jernigan AL; Chaudhuri AR
    Biochem Biophys Res Commun; 2013 Aug; 438(1):218-23. PubMed ID: 23886956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of familial ALS-linked mutant SOD1 solubility with disease progression: its modulation by the proteasome and Hsp70.
    Koyama S; Arawaka S; Chang-Hong R; Wada M; Kawanami T; Kurita K; Kato M; Nagai M; Aoki M; Itoyama Y; Sobue G; Chan PH; Kato T
    Biochem Biophys Res Commun; 2006 May; 343(3):719-30. PubMed ID: 16563356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice.
    Zetterström P; Graffmo KS; Andersen PM; Brännström T; Marklund SL
    J Biol Chem; 2011 Jun; 286(23):20130-6. PubMed ID: 21493711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1
    Mitsui S; Otomo A; Nozaki M; Ono S; Sato K; Shirakawa R; Adachi H; Aoki M; Sobue G; Shang HF; Hadano S
    Mol Brain; 2018 May; 11(1):30. PubMed ID: 29843805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrantly increased hydrophobicity shared by mutants of Cu,Zn-superoxide dismutase in familial amyotrophic lateral sclerosis.
    Tiwari A; Xu Z; Hayward LJ
    J Biol Chem; 2005 Aug; 280(33):29771-9. PubMed ID: 15958382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.
    Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S
    PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1.
    Batulan Z; Shinder GA; Minotti S; He BP; Doroudchi MM; Nalbantoglu J; Strong MJ; Durham HD
    J Neurosci; 2003 Jul; 23(13):5789-98. PubMed ID: 12843283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis.
    Sábado J; Casanovas A; Hernández S; Piedrafita L; Hereu M; Esquerda JE
    J Neuropathol Exp Neurol; 2013 Jul; 72(7):646-61. PubMed ID: 23771221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detergent-insoluble aggregates associated with amyotrophic lateral sclerosis in transgenic mice contain primarily full-length, unmodified superoxide dismutase-1.
    Shaw BF; Lelie HL; Durazo A; Nersissian AM; Xu G; Chan PK; Gralla EB; Tiwari A; Hayward LJ; Borchelt DR; Valentine JS; Whitelegge JP
    J Biol Chem; 2008 Mar; 283(13):8340-50. PubMed ID: 18192269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
    Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of heat shock transcription factor 1 and its downstream target protein T-cell death associated gene 51 in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
    Mimoto T; Morimoto N; Miyazaki K; Kurata T; Sato K; Ikeda Y; Abe K
    Brain Res; 2012 Dec; 1488():123-31. PubMed ID: 23063459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis.
    Roberts BR; Lim NK; McAllum EJ; Donnelly PS; Hare DJ; Doble PA; Turner BJ; Price KA; Lim SC; Paterson BM; Hickey JL; Rhoads TW; Williams JR; Kanninen KM; Hung LW; Liddell JR; Grubman A; Monty JF; Llanos RM; Kramer DR; Mercer JF; Bush AI; Masters CL; Duce JA; Li QX; Beckman JS; Barnham KJ; White AR; Crouch PJ
    J Neurosci; 2014 Jun; 34(23):8021-31. PubMed ID: 24899723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and biophysical properties of the pathogenic SOD1 variant H46R/H48Q.
    Winkler DD; Schuermann JP; Cao X; Holloway SP; Borchelt DR; Carroll MC; Proescher JB; Culotta VC; Hart PJ
    Biochemistry; 2009 Apr; 48(15):3436-47. PubMed ID: 19227972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.